ARTV
Artiva BiotherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
ARTV vs peer average
37/100
ARTV vs. peer average (D vs. C)
Grade spread
A 2 · B 2 · C 3 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
CROX is the first available peer comparator.
Established oncology biotech with commercial assets; serves as an M&A strategic comparitor.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ARTV
Artiva Biotherapeutics
CROX
Crocs
Grade
D
B
Momentum
74
86
Value
42
65
Sentiment
18
35
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs CROX
ARTV / CROX
Grade Position
Below peers
ARTV vs. peer average (D vs. C)
37/100
Momentum
74
CROXValue
42
CROXSentiment
18
CROXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ARTV
CROX is the first peer returned for this comparison set.